logo

The Significance of Moving Averages in Marinus Pharmaceuticals Inc Inc. (MRNS) Price Performance

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -86.48% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -85.29%. Over the past 30 days, the price of MRNS has fallen by 2.80%. And in the last five days, it has surged by 10.53%.

Marinus Pharmaceuticals Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $11.26 on 01/08/24, while the lowest value for the same period was recorded at $1.05 on 08/14/24.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

52-week price history of MRNS Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Marinus Pharmaceuticals Inc’s current trading price is -86.94% away from its 52-week high, while its distance from the 52-week low is 40.00%. The stock’s price range during this period has varied between$1.05 and $11.26. The Marinus Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.88 million for the day, a figure considerably higher than their average daily volume of 0.81 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Marinus Pharmaceuticals Inc (MRNS) has experienced a quarterly rise of 6.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 80.97M and boasts a workforce of 165 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.8355, with a change in price of -7.2300. Similarly, Marinus Pharmaceuticals Inc recorded 1,685,646 in trading volume during the last 100 days, posting a change of -83.10%.

MRNS Stock Stochastic Average

Marinus Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 81.55%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 87.50%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 71.43% and 69.29%, respectively.

Most Popular